![Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/04339364fc49b7c4a495af383707809cd97f0686/2-Figure1-1.png)
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar
![Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295222000235-ga1.jpg)
Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect
![Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661816307137-fx1.jpg)
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
![Schematic flow-chart for the choice of JAK inhibitor treatment in the... | Download Scientific Diagram Schematic flow-chart for the choice of JAK inhibitor treatment in the... | Download Scientific Diagram](https://www.researchgate.net/publication/372073129/figure/fig2/AS:11431281187118602@1694139351249/Schematic-flow-chart-for-the-choice-of-JAK-inhibitor-treatment-in-the-context-of.png)